---
title: "Tmall Health has joined dozens of brands to establish the \"Health Supplement Assurance Alliance\""
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281623439.md"
description: "On April 3rd, Tmall Health, in collaboration with dozens of well-known domestic health supplement companies such as By-Health, Caltrate, Centrum, HPGC, 21st Century, CONBA, GNC, YANGYUAN, Shouxiangu, SenShan, and Nuohui, jointly launched the \"Health Supplement Assurance Alliance.\" The alliance aims to promote standardization, normalization, and transparency in the health supplement industry, advocating for consumers to recognize the \"blue hat\" label when purchasing health supplements and to choose products that better meet the nutritional and health needs of Chinese people"
datetime: "2026-04-03T09:29:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281623439.md)
  - [en](https://longbridge.com/en/news/281623439.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281623439.md)
---

# Tmall Health has joined dozens of brands to establish the "Health Supplement Assurance Alliance"

On April 3rd, Tmall Health, in collaboration with dozens of well-known domestic health supplement companies such as By-Health, Caltrate, Centrum, HPGC, 21st Century, CONBA, GNC, YANGYUAN, Shouxiangu, SenShan, and Nuohui, jointly launched the "Health Supplement Assurance Alliance." The alliance aims to promote the standardization, normalization, and transparency of the health supplement industry, advocating for consumers to recognize the "blue hat" label when purchasing health supplements and to choose products that better meet the nutritional and health needs of Chinese people

### Related Stocks

- [600572.CN](https://longbridge.com/en/quote/600572.CN.md)
- [603896.CN](https://longbridge.com/en/quote/603896.CN.md)
- [600664.CN](https://longbridge.com/en/quote/600664.CN.md)
- [603156.CN](https://longbridge.com/en/quote/603156.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [562050.CN](https://longbridge.com/en/quote/562050.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)
- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [Ab&B Bio-Tech Starts Early-Stage Trials for High-Yield RSV Vaccine as Trading Remains Suspended](https://longbridge.com/en/news/286268861.md)
- [Everest Medicines Director and Major Shareholder Raises Stake in Company](https://longbridge.com/en/news/286481551.md)